Courtagen, SimulConsult Ink Deal for Clinical Interpretation of Genetic Tests | GenomeWeb

NEW YORK (GenomeWeb News) – Under an agreement announced today, Courtagen Life Sciences will incorporate SimulConsult's Genome-Phenome Analyzer into its process for the clinical interpretation of genetic tests.

The Genome-Phenome Analyzer is software that allows researchers to combine a genome variant table with the phenotypic data entered by a clinician "thereby using the full power of genome [and] phenome to arrive at a diagnosis in seconds," SimulConsult said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.